• 1. 蘭州大學(xué)循證醫(yī)學(xué)中心（蘭州 730000）2. 青島大學(xué)醫(yī)院（青島 266071）3. 蘭州大學(xué)循證醫(yī)學(xué)研究所（蘭州 730000）4. 蘭州大學(xué)第一醫(yī)院檢驗(yàn)科（蘭州730000）5. 蘭州大學(xué)病原生物學(xué)研究所（蘭州730000）6. 蘭州大學(xué)第一醫(yī)院普外科（蘭州730000）7. 蘭州理工大學(xué)生命科學(xué)與工程學(xué)院（蘭州 730050）;

目的 　系統(tǒng)評(píng)價(jià)阿苯達(dá)唑治療肝細(xì)粒棘球蚴?。℉CE）的療效。
方法 　通過計(jì)算機(jī)檢索和手工檢索，全面收集阿苯達(dá)唑治療HCE的隨機(jī)和半隨機(jī)對(duì)照試驗(yàn)，按Cochrane協(xié)作網(wǎng)推薦的方法進(jìn)行分析。
結(jié)果 　僅2個(gè)試驗(yàn)符合納入標(biāo)準(zhǔn)，其方法學(xué)質(zhì)量評(píng)價(jià)均為“B”級(jí)。1個(gè)研究比較了阿苯達(dá)唑與甲苯達(dá)唑治療HCE的療效，結(jié)果顯示其包囊數(shù)和病例數(shù)的有效率，兩組差異均無統(tǒng)計(jì)學(xué)意義［RR 1.19，95%CI（0.97，1.46）；RR 1.35，95%CI（0.91，2.00）］。另一個(gè)研究比較了阿苯達(dá)唑聯(lián)合手術(shù)與單純手術(shù)治療HCE的療效，結(jié)果顯示，阿苯達(dá)唑治療1月再手術(shù)與直接手術(shù)療效比較差異無統(tǒng)計(jì)學(xué)意義［RR 1.63，95%CI（0.90，2.93）］，阿苯達(dá)唑治療3月再手術(shù)與直接手術(shù)療效比較差異有統(tǒng)計(jì)學(xué)意義[RR 1.89，95%CI（1.09，3.29）］。
結(jié)論 ?、?阿苯達(dá)唑與甲苯達(dá)唑治療HCE的療效相似；② 阿苯達(dá)唑聯(lián)合手術(shù)治療與單純手術(shù)治療相比，阿苯達(dá)唑治療療程應(yīng)足夠長(zhǎng)（3個(gè)月）才會(huì)顯示出聯(lián)合治療的優(yōu)越性。但由于本系統(tǒng)評(píng)價(jià)納入試驗(yàn)數(shù)和病例數(shù)較少，測(cè)量指標(biāo)不全面，因此會(huì)影響到上述結(jié)論的強(qiáng)度。要確定阿苯達(dá)唑治療HCE的效果，尚需開展更多高質(zhì)量試驗(yàn)。

引用本文： 王濤,劉雅莉,楊克虎,金鳳玲,景濤,曹農(nóng),田金徽,馬彬,楊林. 阿苯達(dá)唑治療肝細(xì)粒棘球蚴病的系統(tǒng)評(píng)價(jià). 中國(guó)循證醫(yī)學(xué)雜志, 2007, 07(11): 789-793. doi: 復(fù)制

1. Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54.
2. Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134．.
3. CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013.
4. Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68.
5. Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229.
6. Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952.
7. Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343.
8. 溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測(cè)定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產(chǎn)物的含量. 地方病通報(bào), 1989, 4(4): 52-54.
9. 柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達(dá)唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國(guó)寄生蟲學(xué)與寄生蟲病雜志, 2001, 19(3): 129-134．.
10. 國(guó)家技術(shù)監(jiān)督局, 中華人民共和國(guó)衛(wèi)生部. 包蟲病診斷標(biāo)準(zhǔn)及處理原則. 中華人民共和國(guó)國(guó)家標(biāo)準(zhǔn), 1997, GB7013.
11. 譚家忠, 王龍文. 阿苯達(dá)唑長(zhǎng)期治療肝包蟲的臨床觀察. 地方病通報(bào). 1995, 10(1): 67-68.
12. 張賀玲, 朱其銀, 荊強(qiáng), 等. 兩種劑型阿苯達(dá)唑治療肝囊型包蟲病的療效對(duì)照觀察, 中國(guó)寄生蟲病防治雜志, 2002, 15(4): 228-229.
13. Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694.
14. Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536.
15. Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035.
16. Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388.
17. Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508.
18. Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717.
19. Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459.
20. Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309.
21. Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133.
22. Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66.
23. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272.
  1. 1. Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54.
  2. 2. Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134．.
  3. 3. CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013.
  4. 4. Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68.
  5. 5. Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229.
  6. 6. Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952.
  7. 7. Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343.
  8. 8. 溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測(cè)定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產(chǎn)物的含量. 地方病通報(bào), 1989, 4(4): 52-54.
  9. 9. 柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達(dá)唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國(guó)寄生蟲學(xué)與寄生蟲病雜志, 2001, 19(3): 129-134．.
  10. 10. 國(guó)家技術(shù)監(jiān)督局, 中華人民共和國(guó)衛(wèi)生部. 包蟲病診斷標(biāo)準(zhǔn)及處理原則. 中華人民共和國(guó)國(guó)家標(biāo)準(zhǔn), 1997, GB7013.
  11. 11. 譚家忠, 王龍文. 阿苯達(dá)唑長(zhǎng)期治療肝包蟲的臨床觀察. 地方病通報(bào). 1995, 10(1): 67-68.
  12. 12. 張賀玲, 朱其銀, 荊強(qiáng), 等. 兩種劑型阿苯達(dá)唑治療肝囊型包蟲病的療效對(duì)照觀察, 中國(guó)寄生蟲病防治雜志, 2002, 15(4): 228-229.
  13. 13. Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694.
  14. 14. Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536.
  15. 15. Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035.
  16. 16. Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388.
  17. 17. Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508.
  18. 18. Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717.
  19. 19. Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459.
  20. 20. Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309.
  21. 21. Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133.
  22. 22. Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66.
  23. 23. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272.